SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-288987
Filing Date
2022-11-18
Accepted
2022-11-18 16:16:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d376529dsc13g.htm SC 13G 41495
  Complete submission text file 0001193125-22-288987.txt   43105
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87880 | Film No.: 221402125
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Opportunities III, LP (Filed by) CIK: 0001950105 (see all company filings)

IRS No.: 871325992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G